Barry Dodd

Dr. Barry Dodd has almost 20 years' experience in regulatory affairs gained within academia, government, consulting and industry working on a range of regulated products including biocides, OTC medicines, medical devices and cosmetics. 

With a passion for biocides, he has contributed to the development, launch and maintenance of globally recognized brands, supporting products from concept through to market launch across multiple international territories. Dr. Dodd thrives on the challenge of working with complex or innovative regulatory scenarios. He can provide innovative scientific, strategic, regulatory and policy advice to clients wishing to place new actives and products on the market and develop robust governance strategies for existing active substances and products regulated within the EU and global markets.

Prior to joining Exponent, Dr. Dodd held the position of Senior Regulatory Manager at Arxada. In this role, he has overall responsibility for leading the regulatory team for the Professional Hygiene, Homecare and Crop business units covering the European, Middle East and African (EMEA) markets. This included the management of biocide and plant protection active substance and product dossiers to support reviews at national and EU level and the implementation of strategies to develop new products and obtain medical device certification for the professional hygiene business unit.

Prior to joining Arxada, Dr. Dodd spent almost 8 years at Reckitt Benckiser where he worked on a range of regulated products including medicines, medical devices, cosmetics and notably biocides, where as the global regulatory manager for the EU, he was responsible for guiding the business and providing strategic advice in supporting many high profile brands through the complexities of the BPR processes.

Dr. Dodd has represented both Arxada and Reckitt Benckiser in the Management Committee of Biocides for Europe, a sector group of CEFIC, the European Chemical Industry Council representing the biocide industry in Europe. As part of the Management Committee, he has driven successful advocacy and policy strategies with regulatory authorities and the European Commission in encouraging pragmatic practical implementation of the EU BPR.

Before joining Reckitt Benckiser, Dr. Dodd spent a year as a regulatory consultant at APC. Specializing in chemistry and residues where he was responsible for the preparation of chemistry and residue dossier sections as well as acting as study monitor for clients registering pesticide and biocidal products in the EU.

Prior to joining APC, Dr. Dodd spent almost 6 years working at the Health and Safety Executives Chemicals Regulation Directorate, the UK regulatory authority on pesticides and biocides. As a higher scientific officer, he fulfilled the role of a chemistry and residues specialist, evaluating data and preparing assessment reports for UK and EU pesticide and biocidal authorizations including consumer exposure assessments and maximum residue level assessments. Whilst at CRD, Dr. Dodd was also the UK regulatory representative at DG SANCO residues working group and standing committee on the food chain and animal health.